HomeCRBP • NASDAQ
add
Corbus Pharmaceuticals Holdings Inc
Previous close
$6.00
Day range
$5.71 - $5.93
Year range
$5.71 - $61.90
Market cap
69.54M USD
Avg Volume
266.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.82M | 22.22% |
Net income | -9.53M | -18.80% |
Net profit margin | — | — |
Earnings per share | -0.78 | 56.91% |
EBITDA | -12.47M | -25.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.06M | 613.01% |
Total assets | 155.88M | 451.35% |
Total liabilities | 13.45M | -61.76% |
Total equity | 142.43M | — |
Shares outstanding | 12.23M | — |
Price to book | 0.51 | — |
Return on assets | -19.69% | — |
Return on capital | -21.02% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.53M | -18.80% |
Cash from operations | -10.94M | -82.12% |
Cash from investing | 8.73M | -15.96% |
Cash from financing | -13.00K | 99.32% |
Net change in cash | -2.22M | -189.90% |
Free cash flow | -8.35M | -110.06% |
About
Founded
Jan 1, 2009
Website
Employees
28
